INO vs OMC · $88.0M cap vs rev $17.27B
Inovio Pharmaceuticals Inc (INO) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
INO currently screens at market cap $88.0M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the INO and OMC stock pages for the full models.
Not investment advice.